CENCORA, INC. Proceeds and Excess Tax Benefit from Share-based Compensation
CENCORA, INC. (COR) reported Proceeds and Excess Tax Benefit from Share-based Compensation of $76.23 million for the 12-month period ending 2019-09-30, per its 10-K filed 2019-11-19.
Discontinued › Notes › Compensation Related Costs
us-gaap:ProceedsAndExcessTaxBenefitFromSharebasedCompensation · last filed 2019-11-19
- CENCORA, INC. proceeds and excess tax benefit from share-based compensation for the quarter ending 2018-09-30 was $10.95M, a 27.32% increase year-over-year.
- CENCORA, INC. proceeds and excess tax benefit from share-based compensation for the quarter ending 2018-06-30 was $12.27M, a 62.74% decline year-over-year.
- CENCORA, INC. proceeds and excess tax benefit from share-based compensation for the quarter ending 2018-03-31 was $85.66M, a 67.46% increase year-over-year.
- CENCORA, INC. proceeds and excess tax benefit from share-based compensation for the quarter ending 2017-12-31 was $29.57M, a 189.12% increase year-over-year.
- CENCORA, INC. proceeds and excess tax benefit from share-based compensation for fiscal 2019 was $76.23M, a 44.94% decline from fiscal 2018.
- CENCORA, INC. proceeds and excess tax benefit from share-based compensation for fiscal 2018 was $138.46M, a 34.52% increase from fiscal 2017.
- CENCORA, INC. proceeds and excess tax benefit from share-based compensation for fiscal 2017 was $102.92M, a 37.66% increase from fiscal 2016.
- CENCORA, INC. proceeds and excess tax benefit from share-based compensation for fiscal 2016 was $74.77M, a 61.46% decline from fiscal 2015.
| Period end | Proceeds and Excess Tax Benefit from Share-based Compensation 3 month | Proceeds and Excess Tax Benefit from Share-based Compensation 6 month | Proceeds and Excess Tax Benefit from Share-based Compensation 9 month | Proceeds and Excess Tax Benefit from Share-based Compensation 12 month |
|---|---|---|---|---|
| 2019-09-30 | $76.23M 10-K · filed 2019-11-19 | |||
| 2018-09-30 | $10.95M derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-19 | $23.22M derived: sum of 2 quarters · filed 2019-11-19 | $108.88M derived: sum of 3 quarters · filed 2019-11-19 | $138.46M 10-K · filed 2019-11-19 |
| 2018-06-30 | $12.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-02 | $97.94M derived: sum of 2 quarters · filed 2018-08-02 | $127.51M 10-Q · filed 2018-08-02 | $136.11M derived: sum of 4 quarters · filed 2019-11-19 |
| 2018-03-31 | $85.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-02 | $115.24M 10-Q · filed 2018-05-02 | $123.83M derived: sum of 3 quarters · filed 2019-11-19 | $156.78M derived: sum of 4 quarters · filed 2019-11-19 |
| 2017-12-31 | $29.57M 10-Q · filed 2018-02-06 | $38.17M derived: sum of 2 quarters · filed 2019-11-19 | $71.11M derived: sum of 3 quarters · filed 2019-11-19 | $122.27M derived: sum of 4 quarters · filed 2019-11-19 |
| 2017-09-30 | $8.60M derived: 10-K 12 month − 10-Q 9 month · filed 2019-11-19 | $41.54M derived: sum of 2 quarters · filed 2019-11-19 | $92.69M derived: sum of 3 quarters · filed 2019-11-19 | $102.92M 10-K · filed 2019-11-19 |
| 2017-06-30 | $32.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-08-02 | $84.10M derived: sum of 2 quarters · filed 2018-08-02 | $94.33M 10-Q · filed 2018-08-02 | $95.74M derived: sum of 4 quarters · filed 2018-11-20 |
| 2017-03-31 | $51.15M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-05-02 | $61.38M 10-Q · filed 2018-05-02 | $62.80M derived: sum of 3 quarters · filed 2018-11-20 | $98.87M derived: sum of 4 quarters · filed 2018-11-20 |
| 2016-12-31 | $10.23M 10-Q · filed 2018-02-06 | $11.64M derived: sum of 2 quarters · filed 2018-11-20 | $47.71M derived: sum of 3 quarters · filed 2018-11-20 | $51.02M derived: sum of 4 quarters · filed 2018-11-20 |
| 2016-09-30 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2018-11-20 | $37.48M derived: sum of 2 quarters · filed 2018-11-20 | $40.79M derived: sum of 3 quarters · filed 2018-11-20 | $74.77M 10-K · filed 2018-11-20 |
| 2016-06-30 | $36.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-08-03 | $39.38M derived: sum of 2 quarters · filed 2017-08-03 | $73.36M 10-Q · filed 2017-08-03 | $89.20M derived: sum of 4 quarters · filed 2017-11-21 |
| 2016-03-31 | $3.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-05-04 | $37.28M 10-Q · filed 2017-05-04 | $53.13M derived: sum of 3 quarters · filed 2017-11-21 | $89.38M derived: sum of 4 quarters · filed 2017-11-21 |
| 2015-12-31 | $33.98M 10-Q · filed 2017-01-31 | $49.83M derived: sum of 2 quarters · filed 2017-11-21 | $86.08M derived: sum of 3 quarters · filed 2017-11-21 | $187.81M derived: sum of 4 quarters · filed 2017-11-21 |
| 2015-09-30 | $15.85M derived: 10-K 12 month − 10-Q 9 month · filed 2017-11-21 | $52.10M derived: sum of 2 quarters · filed 2017-11-21 | $153.83M derived: sum of 3 quarters · filed 2017-11-21 | $193.99M 10-K · filed 2017-11-21 |
| 2015-06-30 | $36.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-08-02 | $137.98M derived: sum of 2 quarters · filed 2016-08-02 | $178.15M 10-Q · filed 2016-08-02 | $196.36M derived: sum of 4 quarters · filed 2016-11-22 |
| 2015-03-31 | $101.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-05-05 | $141.90M 10-Q · filed 2016-05-05 | $160.11M derived: sum of 3 quarters · filed 2016-11-22 | $210.13M derived: sum of 4 quarters · filed 2016-11-22 |
| 2014-12-31 | $40.16M 10-Q · filed 2016-02-04 | $58.38M derived: sum of 2 quarters · filed 2016-11-22 | $108.39M derived: sum of 3 quarters · filed 2016-11-22 | $135.74M derived: sum of 4 quarters · filed 2016-11-22 |
| 2014-09-30 | $18.21M derived: 10-K 12 month − 10-Q 9 month · filed 2016-11-22 | $68.23M derived: sum of 2 quarters · filed 2016-11-22 | $95.58M derived: sum of 3 quarters · filed 2016-11-22 | $127.91M 10-K · filed 2016-11-22 |
| 2014-06-30 | $50.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-08-06 | $77.37M derived: sum of 2 quarters · filed 2015-08-06 | $109.69M 10-Q · filed 2015-08-06 | $132.64M derived: sum of 4 quarters · filed 2015-11-24 |
| 2014-03-31 | $27.35M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-05-08 | $59.67M 10-Q · filed 2015-05-08 | $82.62M derived: sum of 3 quarters · filed 2015-11-24 | $149.54M derived: sum of 4 quarters · filed 2015-11-24 |
| 2013-12-31 | $32.33M 10-Q · filed 2015-02-06 | $55.27M derived: sum of 2 quarters · filed 2015-11-24 | $122.19M derived: sum of 3 quarters · filed 2015-11-24 | $148.29M derived: sum of 4 quarters · filed 2015-11-24 |
| 2013-09-30 | $22.95M derived: 10-K 12 month − 10-Q 9 month · filed 2015-11-24 | $89.86M derived: sum of 2 quarters · filed 2015-11-24 | $115.96M derived: sum of 3 quarters · filed 2015-11-24 | $155.71M 10-K · filed 2015-11-24 |
| 2013-06-30 | $66.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-07 | $93.02M derived: sum of 2 quarters · filed 2014-08-07 | $132.77M 10-Q · filed 2014-08-07 | |
| 2013-03-31 | $26.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-07 | $65.85M 10-Q · filed 2014-05-07 | ||
| 2012-12-31 | $39.75M 10-Q · filed 2014-02-07 | |||
| 2012-06-30 | $91.09M 10-Q · filed 2013-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CARDINAL HEALTH INC (CAH) | United States | $51.753B | 29.38 |
| MCKESSON CORP (MCK) | United States | $101.317B | 19.78 |
| HERBALIFE LTD. (HLF) | $1.281B | 8.39 | |
| NU SKIN ENTERPRISES, INC. (NUS) | United States | $0.225B | -1.18 |
| Cosmos Health Inc. (COSM) | Greece | $0.038B | -0.60 |
| HWH International Inc. (HWH) | United States | $0.021B | -4.08 |
| DataMeds AI, Inc. (MEDS) | United States | $0.011B |